WALTHAM, MA – October 3, 2018 – Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that its CorPath GRX System was used for multiple complex robotic-assisted percutaneous coronary interventions (PCI) at the recent Transcatheter Cardiovascular Therapeutics (TCT) 2018 Conference. In the first case at University of Washington Medical Center, Dr. William Lombardi, a high volume chronic total occlusion (CTO) PCI operator, performed the first live transmission of a hybrid CTO PCI using both manual and robotic techniques to successfully treat a patient suffering from a complete coronary artery blockage. Simultaneously, at UC San Diego, Dr. Ehtisham Mahmud performed a robotic-assisted CHIP (Complex Higher-Risk Indicated Patients) case utilizing multiple interventional devices. Both demonstrations were broadcast live during TCT to thousands of conference attendees. Recordings of the live cases can be viewed by visiting tctmd.com/tct2018.

In addition, the first live transmission of a remote robotic demonstration was streamed from Mayo Clinic using CorPath GRX with developmental remote technology, giving Dr. Gurpreet Sandhu the ability to remotely manipulate interventional devices within a porcine model's arteries while located in a different building.

William Lombardi, M.D., Interventional Cardiologist at the University of Washington Medical Center, stated, "The robot's ability to precisely manipulate devices, specifically the controlled movement of the guide, is very impressive. Since incorporating robotics into my program, I've been able to reduce my time in lead by almost 40% which is especially valuable for the long, complex cases I perform."
Mark Toland, President and Chief Executive Officer of Corindus, stated, "This year's TCT meeting celebrated 30 years of groundbreaking science and innovation. We are pleased that advanced vascular robotic technology and its role in complex interventions was a prevalent theme throughout the conference."


About Transcatheter Cardiovascular Therapeutics (TCT)
TCT is the world's largest and most important educational meeting specializing in interventional cardiovascular medicine. For 30 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research. The symposium is designed for interventional cardiologists, radiologists, clinical cardiologists, scientists, vascular medicine specialists, cardiac and vascular surgeons, nurse practitioners, cath lab technicians, and other healthcare professionals with a special interest in the field of interventional and vascular medicine.

Operating Room Homepage